Lymphocytic alimentary lymphoma in a feline: therapy with lomustine and prednisone - Case report
DOI:
https://doi.org/10.31533/pubvet.v13n6a351.1-5Keywords:
cats, lomustine, oncology, small animals, chemotherapyAbstract
Among the hematopoietic neoplasms most observed in the feline species, lymphoma is mentioned. Being classified according to the anatomical site affected. The alimentary form is considered the second most common neoplasia found in the gastrointestinal tract of cats, which can affect the liver, spleen and pancreas. Older animals and/or retrovirus carriers have a bigger risk for the development of the disease. Clinical symptomatology varies according to the location, the age of the patient and the presence or absence of comorbidities. The treatment of the lymphocytic alimentary lymphoma aims to improve quality and increase the life span of patients. Thus, the importance of early diagnosis, through hematological, biochemical and imaging tests, as well as intestinal biopsy is highlighted. The follow-up of patients belonging to the risk group is also another essential factor for the recognition of the disease. The objective of this work is to report the case of a seven-year-old female feline with a history of hyporexia, prostration, emesis and progressive weight loss. After further examination, it was diagnosed a lymphocytic alimentary lymphoma and the treatment was with chemotherapy with lomustine and prednisone. The therapy demonstrated few side effects and an efficient response to disease control.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Bruna Cenci Ortiz, César Augusto Soares, Veridiane da Rosa Gomes, Priscila Secchi, Francisco Jorge Schulz Júnior, Maria Inês Witz, Gisele Barcelos Seberino
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato
Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
O licenciante não pode revogar estes direitos desde que você respeite os termos da licença. De acordo com os termos seguintes:
Atribuição
— Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso. Sem restrições adicionais
— Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.